| Value | ₹1,885 Cr |
|---|
NSE filing, NSE: RATEGAIN. Summary written from the filing by ALFA Finder's alert engine.
RateGain Travel Technologies Ltd: key numbers
- Share price
- ₹819.45
- Market cap
- ₹9,715 Cr
- Revenue (annual)
- ₹1,824 Cr
- Net profit (annual)
- ₹194.4 Cr
- P/E (TTM)
- 40.1×Sector 23.4×
- Promoter holding
- 48.86%+0.08% QoQ
- FII holding
- 6.89%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from RateGain Travel Technologies Ltd
All →RateGain Travel Technologies Results Update
RateGain reported Q2 FY27 operating revenue of INR 745.4 Cr, up 152.6% YoY, with adjusted EBITDA margin at 22.7%. Adjusted PAT rose 78% YoY to INR 90.8 Cr.
RateGain Travel Technologies Investor Presentation: Key Takeaways
Q2 FY27 operating revenue INR 745.4 Cr (+152.6% YoY), Adj. EBITDA INR 169.1 Cr (22.7% margin), Adj. PAT INR 90.8 Cr. Growth is Sojern-driven and integration is ongoing.
RateGain Travel Technologies Q2 FY27 Results: Net Profit ₹74.7 Cr, Up 46.5% YoY
RateGain Travel Technologies Ltd reported revenue from operations of ₹745.4 Cr (+152.6% YoY) and net profit of ₹74.7 Cr (+46.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹74.7 Cr · +46.5% YoY
RateGain Travel Technologies Debt & Borrowing: ₹434.8 Cr
RateGain Travel Technologies' UK subsidiary has prepaid USD 46.25 Million (approx. ₹434.75 Crore) of its loan facility. This reduces the outstanding debt to USD 31.25 Million.
- Value
- ₹434.8 Cr
RateGain Travel Technologies Board Meeting Date
RateGain Travel Technologies will hold a board meeting on 5 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window closes from 1 October 2026 until 48 hours after results.
RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Other results update announcements
All →Paras Healthcare Results Update
Paras Healthcare reported Q2 FY27 revenue of Rs. 510.9 crore, up 22.8% YoY, through a press release. These are its first results since its October 2026 listing.
AstraZeneca Pharma India Results Update
AstraZeneca Pharma India reported 30% growth in Q2 results, with three new regulatory approvals. It also announced MoUs with two state governments.
BCPL Railway Infrastructure Results Update
BCPL Railway's H1 FY27 standalone revenue fell 7.80% to Rs 4,982.46 lacs, while consolidated revenue rose 26.44% to Rs 16,209.53 lacs. Consolidated PAT was Rs 527.66 lacs.
Meta Infotech Results Update
Meta Infotech's H1FY27 revenue fell 57% YoY to Rs 895 Million, while PAT was Rs 49 Million. Gross margin improved to 32.2% as it shifted toward services.
B.R.Goyal Infrastructure Results Update
B.R.Goyal Infrastructure released H1 FY27 unaudited results, with revenue up 60.67% and PAT up 37.82%. Order book stood at Rs 1,755 Crore on September 30, 2026.
Sula Vineyards Results Update
Sula Vineyards reported Q2 FY27 net profit up 34% YoY to Rs 8.1 Crore. The release also flags a fourth hotel and upcoming product launches.